Soleno Therapeutics, Inc. (SLNO)

NASDAQ: SLNO · Real-Time Price · USD

37.72

-1.34 (-3.43%)

At close: Mar 3, 2026, 4:00 PM EST

38.20

+0.48 (1.27%)

After-hours: Mar 3, 2026, 7:18 PM EST

Soleno Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	70.11	87.93	169.68	14.6	21.3
Short-Term Investments	235.37	203.51	-	-	-
Cash & Short-Term Investments	305.47	291.44	169.68	14.6	21.3
Cash Growth	4.82%	71.76%	1062.04%	-31.46%	-56.72%
Accounts Receivable	28.21	-	-	-	-
Receivables	28.21	-	-	-	-
Inventory	15.02	-	-	-	-
Prepaid Expenses	7.11	2.45	1.68	1.05	1.12
Total Current Assets	355.81	293.89	171.36	15.65	22.42
Property, Plant & Equipment	2.38	2.98	0.42	0.16	0.45
Long-Term Investments	200.62	27.21	-	-	-
Other Intangible Assets	4.86	6.81	8.75	10.69	12.64
Other Long-Term Assets	0.16	0.08	0.17	-	0.04
Total Assets	563.83	330.97	180.69	26.5	35.55
Accounts Payable	12.44	8.88	3.15	1.78	3.25
Accrued Expenses	27.82	9.34	6.53	4.9	4.15
Current Portion of Leases	0.73	0.53	0.27	0.16	0.28
Other Current Liabilities	20.38	-	1.56	0.48	0.32
Total Current Liabilities	61.36	18.75	11.51	7.31	8.01
Long-Term Debt	49.86	49.83	-	-	-
Long-Term Leases	1.96	2.47	0.13	-	0.18
Other Long-Term Liabilities	0.53	14.81	11.55	8.84	9.58
Total Liabilities	113.72	85.86	23.18	16.15	17.76
Common Stock	0.05	0.05	0.03	0.01	0.08
Additional Paid-In Capital	881.02	696.97	433.89	247.76	231.07
Retained Earnings	-431.37	-452.26	-276.41	-237.42	-213.36
Comprehensive Income & Other	0.42	0.36	-	-	-
Total Common Equity	450.12	245.11	157.51	10.35	17.79
Shareholders' Equity	450.12	245.11	157.51	10.35	17.79
Total Liabilities & Equity	563.83	330.97	180.69	26.5	35.55
Total Debt	52.55	52.83	0.4	0.16	0.46
Net Cash (Debt)	453.54	265.82	169.28	14.45	20.85
Net Cash Growth	70.62%	57.03%	1071.72%	-30.70%	-57.52%
Net Cash Per Share	8.66	6.62	10.26	1.72	3.92
Filing Date Shares Outstanding	51.62	45.86	32.46	8.17	5.34
Total Common Shares Outstanding	52.29	45.7	31.68	8.16	5.32
Working Capital	294.45	275.14	159.85	8.33	14.42
Book Value Per Share	8.61	5.36	4.97	1.27	3.34
Tangible Book Value	445.25	238.31	148.76	-0.35	5.16
Tangible Book Value Per Share	8.52	5.21	4.70	-0.04	0.97
Machinery	0.22	0.2	0.1	0.1	0.1
Leasehold Improvements	0.09	0.05	-	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q